Clinical trial
Allogeneic Stem Cell Transplantation for Myelofibrosis and Myelodysplastic…
NCT00475020 · M.D. Anderson Cancer Center, Other · Completed
Key facts
| NCT number | NCT00475020 |
|---|---|
| Title | Allogeneic Stem Cell Transplantation for Myelofibrosis and Myelodysplastic Syndrome |
| Official title | Allogeneic Stem Cell Transplantation for Myelofibrosis and Myelodysplastic Syndrome Using Reduced Intensity Busulfan and Fludarabine Conditioning |
| Lead sponsor | M.D. Anderson Cancer Center, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Myelofibrosis |
| Intervention type | Drug |
| Interventions | Busulfan, Fludarabine, Thymoglobulin (ATG) |
| Enrollment | 63 |
| Start date | Jan 4, 2006 |
| Primary completion | Oct 4, 2017 |
| Completion | Oct 4, 2017 |
| First posted | May 17, 2007 |
| Last update posted | May 21, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: